Project Grant R35GM161902
- Federal Project Grant Award Summary The University of Pennsylvania received a $406,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, through December 31, 2030. This award funds the development of correlated factor models and advanced statistical methodologies for exploratory analysis of complex multimodal study designs in biomedical research. The project delivers...
- Federal Grant Award Summary The University of Pennsylvania received a $148,050 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2025, through May 31, 2027. The award funds fundamental biomedical research investigating the role of protein arginine methyltransferase 1 (PRMT1) and heterogeneous nuclear ribonucleoprotein K (HNRNPK) in regulating the spatial organization of...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Pennsylvania a $812,500 Project Grant effective June 1, 2025, through April 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports fundamental research into the mechanisms driving complex and reproducible developmental outcomes in multicellular organisms. The research encompasses two primary directions: (1) investigating how...
- Federal Grant Award Summary The University of Pennsylvania received a $731,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025, through April 30, 2029. This award funds fundamental research to elucidate the mechanisms by which TET (ten-eleven translocation) family enzymes mediate active DNA demethylation through oxidation of 5-methylcytosine (5mc) in genomic DNA. The...
- Federal Grant Award Summary The University of Pennsylvania received a $443,806 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award supports fundamental research investigating the coordination of chemical modifications across multiple ribonucleic acid (RNA) species, specifically examining how enzyme-mediated modifications to...
- Federal Project Grant Award Summary The University of Pennsylvania received a $956,510 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025 through March 31, 2030. The award funds fundamental research to elucidate the molecular mechanisms and evolutionary conservation of the rhoptry secretion system in unicellular eukaryotes within the Alveolata superphylum, including...
- Federal Grant Award Summary The University of Pennsylvania received a $478,621 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. This award supports fundamental research into the epigenetic regulation and function of imprinted genes in mammals. The research will elucidate the mechanisms by which parental identity of imprinted genes is...
- Federal Project Grant Award Summary The University of Pennsylvania received a $924,095 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) for the period April 1, 2026 through March 31, 2031. This award supports fundamental research investigating the molecular mechanisms controlling actin cytoskeleton dynamics, a critical area of cell biology with broad implications for understanding cellular...
- Federal Project Grant Award Summary The University of Pennsylvania received a $446,875 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on April 6, 2026, with a completion date of December 31, 2030. This five-year research initiative focuses on elucidating the mechanisms and roles of RNA editing and sensing in RNA-mediated immune regulation. The project aims to advance understanding of...
- Federal Project Grant Award Summary The University of Pennsylvania received a $406,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 2, 2026, with a completion date of December 31, 2030. This five-year research initiative focuses on advancing nucleic acid chemistry and developing xeno nucleic acids (XNAs)—synthetic nucleic acid analogs with modified backbones—to expand...
The University of Pennsylvania received a $688,506 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. The award funds integrative genomic research investigating human evolution and complex traits in African populations, addressing critical gaps in understanding African genomic and phenotypic variation. The research project will deliver comprehensive analyses incorporating genomic, metabolomic, proteomic, microbiome, epigenomic, and transcriptomic data combined with detailed phenotypic characterization to reconstruct population history and elucidate how genetic and environmental variation impacts anthropometric, cardio-metabolic, and immune-related traits. The project will produce multiple research outputs including assessments of polygenic risk score effectiveness across African and non-African populations, characterization of gene-by-environment interactions, functional genomic studies utilizing high-throughput luciferase reporter assays, validation studies employing CRISPR-Cas9 technology in human cells and model systems, and comprehensive microbiome diversity analysis. These research deliverables will generate enhanced understanding of human genomic variation, population structure, and linkage disequilibrium patterns critical for genome-wide association studies in multi-ancestry populations, with direct implications for understanding the genetic basis of disease-relevant intermediate phenotypes in diverse global populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $688.5k | 3/23/26 |